1. Home
  2. SPRU vs GRDX Comparison

SPRU vs GRDX Comparison

Compare SPRU & GRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spruce Power Holding Corporation

SPRU

Spruce Power Holding Corporation

HOLD

Current Price

$1.46

Market Cap

30.0M

ML Signal

HOLD

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

SELL

Current Price

$4.46

Market Cap

28.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SPRU
GRDX
Founded
2008
N/A
Country
United States
United Kingdom
Employees
4
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.0M
28.6M
IPO Year
2019
2016

Fundamental Metrics

Financial Performance
Metric
SPRU
GRDX
Price
$1.46
$4.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 155.0K
85.8K
Earning Date
11-10-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 62.30
21.95
EPS
★ 0.02
N/A
Revenue
★ $23,194,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$73.50
★ N/A
Revenue Growth
★ 48.68
N/A
52 Week Low
$1.46
$1.87
52 Week High
$6.75
$6.93

Technical Indicators

Market Signals
Indicator
SPRU
GRDX
Relative Strength Index (RSI) 32.80 58.57
Support Level N/A $2.37
Resistance Level $1.90 $6.93
Average True Range (ATR) 0.08 0.50
MACD -0.02 0.07
Stochastic Oscillator 0.00 69.16

Price Performance

Historical Comparison
SPRU
GRDX

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: